Form 8-K - Current report:
SEC Accession No. 0001493152-25-013167
Filing Date
2025-09-12
Accepted
2025-09-12 14:53:18
Documents
14
Period of Report
2025-09-12
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 41038
2 EX-99.1 ex99-1.htm EX-99.1 13533
3 GRAPHIC ex99-1_001.jpg GRAPHIC 12460
  Complete submission text file 0001493152-25-013167.txt   244476

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE curx-20250912.xsd EX-101.SCH 3065
5 XBRL LABEL FILE curx-20250912_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE curx-20250912_pre.xml EX-101.PRE 22392
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3850
Mailing Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753
Business Address 2 JERICHO PLAZA, SUITE101B JERICHO NY 11753 718-673-6078
Curanex Pharmaceuticals Inc (Filer) CIK: 0002025942 (see all company filings)

EIN.: 830741390 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42815 | Film No.: 251311171
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)